Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,914 | -18,248 | -17,368 | 9,142 | 23,371 |
| Depreciation Amortization | -1,856 | -475 | -830 | -621 | -119 |
| Accounts receivable | -35,481 | 1,367 | 1,090 | 1,474 | 1,234 |
| Accounts payable and accrued liabilities | 638 | 67 | 221 | -434 | -853 |
| Other Working Capital | -12,627 | -12,664 | -68,576 | -69,010 | -65,676 |
| Other Operating Activity | 44,623 | 4,404 | 9,876 | 7,105 | 5,247 |
| Operating Cash Flow | $-43,617 | $-25,549 | $-75,587 | $-52,344 | $-36,796 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -186,824 | -192,777 | -59,524 | -45,306 | -45,618 |
| PPE Investments | N/A | N/A | -220 | -19 | -146 |
| Investing Cash Flow | $-186,824 | $-192,777 | $-59,744 | $-45,325 | $-45,764 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 234,998 | 228,632 | 110,446 | 93,803 | 93,550 |
| Other Financing Activity | 0 | 5,855 | 0 | 0 | 0 |
| Financing Cash Flow | $234,998 | $234,487 | $110,446 | $93,803 | $93,550 |
| Beginning Cash Position | 14,194 | 14,194 | 39,079 | 39,079 | 39,079 |
| End Cash Position | 18,751 | 30,355 | 14,194 | 35,213 | 50,069 |
| Net Cash Flow | $4,557 | $16,161 | $-24,885 | $-3,866 | $10,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,617 | -25,549 | -75,587 | -52,344 | -36,796 |
| Capital Expenditure | N/A | N/A | -220 | -19 | -146 |
| Free Cash Flow | -43,617 | -25,549 | -75,807 | -52,363 | -36,942 |